BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pediatric Endocrine Society - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pediatric Endocrine Society
X-ORIGINAL-URL:https://pedsendo.org
X-WR-CALDESC:Events for Pediatric Endocrine Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250123T130000
DTEND;TZID=America/New_York:20250123T140000
DTSTAMP:20241219T145111Z
CREATED:20241218T192839Z
LAST-MODIFIED:20241219T145111Z
UID:24858-1737637200-1737640800@pedsendo.org
SUMMARY:PES State of the Art Webinar: Fair Game? Sex and Gender Categorization in Elite Sports
DESCRIPTION:PES State of the Art Webinar: DSD SIG\, Ethics SIG & Society of Pediatric Psychology DSD SIG \nSession Title: Fair Game? Sex and Gender Categorization in Elite Sports \nBrief Description: \nThe debate over the participation of athletes with sex and gender variations has become heated\, often politicized\, but rarely relying on science. This session will offer a reflection on the balance of fairness and inclusion in elite sports\, information on the factors determining sex development and its variations (Differences of Sex Development-DSD) and how they may be relevant to sports performance\, and a discussion on whether policy-making by sports authorities is or should be influenced by science. \nLearning Objectives: \n\nUnderstand the principles of biological sex determination in humans\nUnderstand the biological underpinnings of human Differences of Sex Development.\nThink critically about policies on sex and gender categorization in elite sports.\n\nSpeaker: \nEric Vilain\, MD\, PhD\nAssociate Vice Chancellor\, Scientific Affairs\, Health Affairs\nDirector\, Institute for Clinical and Translational Science\nProfessor\, Department of Pediatrics\nUniversity of California\, Irvine
URL:https://pedsendo.org/event/pes-state-of-the-art-webinar-fair-game-sex-and-gender-categorization-in-elite-sports/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250127T160000
DTEND;TZID=America/New_York:20250127T170000
DTSTAMP:20250103T181056Z
CREATED:20241002T182626Z
LAST-MODIFIED:20250103T181056Z
UID:24463-1737993600-1737997200@pedsendo.org
SUMMARY:Quarterly Education Committee Webinar: Evaluation of new presentations of POI\, including use of biomarkers\, and genetic landscape
DESCRIPTION:Date: Monday\, January 27\, 2025 / 4:00 pm – 5:00 pm EST \nTitle: Evaluation of new presentations of POI\, including use of biomarkers\, and genetic landscape \nDescription: An in-depth look at primary ovarian insufficiency \nLearning objectives: \n\nTo categorize the genetics of age at menopause and primary ovarian insufficiency (POI)\nTo list phenotypes associated with POI\nTo understand the limitations of AMH as a biomarker\n\nSpeaker: \nCorrine K. Welt\, MD \nDepartment of Internal Medicine Division of Endocrinology and Metabolism \nSchool of Medicine \nRegister Here
URL:https://pedsendo.org/event/quarterly-education-committee-webinar-evaluation-of-new-presentations-of-poi-including-use-of-biomarkers-and-genetic-landscape/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250128T120000
DTEND;TZID=America/New_York:20250128T130000
DTSTAMP:20241217T190534Z
CREATED:20241112T224638Z
LAST-MODIFIED:20241217T190534Z
UID:24636-1738065600-1738069200@pedsendo.org
SUMMARY:PES TREND SIG: Who? What? When?  Current approaches to nuclear imaging  and radiotherapeutics for Pediatric Neuroendocrine Tumors
DESCRIPTION:Tuesday\, January 28\, 2025 \n12:00 PM EST \nSession Title Who? What? When?  Current approaches to nuclear imaging  and radiotherapeutics for Pediatric Neuroendocrine Tumors \nBrief Description \nThis session will focus on use of radioisotopes for imaging and treatment of neuroendocrine neoplasms. \n Learning Objectives  \n\nTo describe common diagnostic uses for radioisotopes in evaluation of suspected/confirmed pediatric neuroendocrine neoplasms and to guide selection of isotopes\nTo articulate therapeutic applications for radiopharmaceuticals in treatment of neuroendocrine tumors.\nTo identify novel/emerging radioisotopes in the evaluation and treatment of pediatric NENs\n\n  \nSpeaker Name \nLisa States\, MD\,\nChildrens Hospital of Philadelphia \n  \nRegister Here
URL:https://pedsendo.org/event/pes-trend-sig-functional-imaging-of-pediatric-neuroendocrine-neoplasms-who-what-when/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250129T180000
DTEND;TZID=America/New_York:20250129T183000
DTSTAMP:20250110T153933Z
CREATED:20241220T151050Z
LAST-MODIFIED:20250110T153933Z
UID:24867-1738173600-1738175400@pedsendo.org
SUMMARY:Industry Sponsored Symposium: From Referral to Resolution: Untangling the Diagnosis and Treatment of Lipodystrophy
DESCRIPTION:Industry Sponsored Symposium: From Referral to Resolution: Untangling the Diagnosis and Treatment of Lipodystrophy \nWednesday\, January 29th\, 2025 | 6:00–6:20 pm ET \nSponsored by Chiesi \n PROGRAM DESCRIPTION \nThe educational webinar will be a brief case presentation by Dr. Nivedita Patni of a pediatric patient with Acquired Generalized Lipodystrophy. Dr. Patni will discuss the patient presentation\, diagnosis\, and management strategies she utilized as well as best practices in lipodystrophy. The 20-minute webinar will have the following objectives: \nLearning objectives: \n\nTo identify the hallmark clinical signs and symptoms associated with lipodystrophy syndromes\nTo discuss the utilization of various tools to help establish a diagnosis for lipodystrophy\nTo gain a practical understanding of the management of patients with lipodystrophy and key considerations for treatment\n\nSpeaker: \nCARLOS FERREIRA\, MD \nNivedita Patni M.D. Associate Professor of Pediatrics Division of Pediatric Endocrinology UT Southwestern Medical Center \nRegister here
URL:https://pedsendo.org/event/industry-sponsored-symposium-from-referral-to-resolution-untangling-the-diagnosis-and-treatment-of-lipodystrophy/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250205T110000
DTEND;TZID=America/New_York:20250205T120000
DTSTAMP:20241121T191532Z
CREATED:20241112T225140Z
LAST-MODIFIED:20241121T191532Z
UID:24640-1738753200-1738756800@pedsendo.org
SUMMARY:PES Turner Syndrome SIG: Navigating Fertility Dilemmas in Turner Syndrome
DESCRIPTION:Wednesday\, February 5\, 2025 \nSession Title Navigating Fertility Dilemmas in Turner Syndrome \nBrief Description \nDr. van der Velden will discuss the current landscape for fertility preservation in individuals with Turner Syndrome\, current challenges and future directions.  She will share expertise in this area gained from leading Turner Fertility trials and leadership during the creation of the updated Turner Syndrome clinical guidelines.  We would like to request a February date to coincide with Turner Syndrome Awareness Month. \n Learning Objectives  \n\nUnderstand current recommendations for fertility preservation for individuals with Turner Syndrome\nLearn about the different challenges experienced by patients and providers\nGain insight about how to help patients and their families navigate fertility preservation\n\n Speaker Name \nJaniëlle van der Velden\, MD\,  PhD\,\nProfessor of Pediatrics\,\nPediatric Endocrinologist\, Principal Lecturer\nDepartment of Pediatric Endocrinology\, Radboud University Medical Center\, Amalia Children’s Hospital\, The Netherlands \nRegister Here
URL:https://pedsendo.org/event/pes-turner-syndrome-sig-navigating-fertility-dilemmas-in-turner-syndrome/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250210T150000
DTEND;TZID=America/New_York:20250210T170000
DTSTAMP:20250219T151748Z
CREATED:20241112T231954Z
LAST-MODIFIED:20250219T151748Z
UID:24644-1739199600-1739206800@pedsendo.org
SUMMARY:PES PedsENDO365: Career Pathways of Pediatric Endocrine Fellows
DESCRIPTION:Monday\, February\, 10\, 2025 \n03:00 pm – 5:00 pm EST \nSession Type: PedsENDO365 \nSession Title: Career Pathways of Pediatric Endocrine Fellows \nBrief Description: This activity addresses the following key concepts: 1. Common viable career paths after fellowship training. 2. Importance of identifying what paths match values\, skills\, and interests 3. Role of networking in identifying mentors and job prospects. \nLearning objectives: \n\nDescribe the career pathways available after endocrine fellowship\nIdentify what career pathway/s match your skills\, values\, and interests.\nEvaluate two possible career paths and the next steps needed via networking with professionals at various stages of a career in that track (clinician-scientist (basic/clinical)\, clinician-educator\, industry\, private practice)\n\nSpeaker: \n\nAmy Levenson\nKathleen Timme\nRona Sonabend\nAlissa Guarneri\nAristides Maniatis\nSonali Malhotra\nAshwini Malappa\nMary Ellen Vajravelu\nKanakadurga Singer\nLeena Nahata\nAmit Lahoti\nNidhi Bansal\nKanthi Bangalore Krishna\n\nRegister Here
URL:https://pedsendo.org/event/pes-pedsendo365-career-pathways-of-pediatric-endocrine-fellows/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250219T173000
DTEND;TZID=America/New_York:20250219T190000
DTSTAMP:20250210T160428Z
CREATED:20241112T232346Z
LAST-MODIFIED:20250210T160428Z
UID:24646-1739986200-1739991600@pedsendo.org
SUMMARY:PES Ethics SIG: Ethics Case-Based Discussion
DESCRIPTION:Wednesday\, February 12\, 2025 \nSession Type SIG: State of the Art: Ethics SIG \nSession Title Ethics Case-Based Discussion \nBrief Description \nJoin the PES Ethics SIG for a discussion of clinical cases that raise ethical questions. \nPES members are invited to submit cases with ethical dilemmas to present for discussion for this webinar. \nCases should be submitted to camilia_kamoun@med.unc.edu by January 17\, 2025. Two to three cases will be selected for presentation. \n  \nLearning Objectives  \n\nIdentify ethical dilemmas in pediatric endocrinology\nDescribe ethical approaches to clinical care in pediatric endocrinology\nDefine key ethical principles to guide clinical care in pediatric endocrinology\n\n  \nSpeaker Name \nPES Ethics SIG Chair will lead the discussion with possible guest speaker \nRegister Here \n**EDIT – moved from Feb 12 to Feb 19; 5:30pET
URL:https://pedsendo.org/event/pes-ethics-sig-ethics-case-based-discussion/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250317T160000
DTEND;TZID=America/New_York:20250317T170000
DTSTAMP:20241121T191417Z
CREATED:20241002T182934Z
LAST-MODIFIED:20241121T191417Z
UID:24467-1742227200-1742230800@pedsendo.org
SUMMARY:Quarterly Education Committee Webinar: Navigating the world of ever-changing treatments for youth-onset type 2 diabetes
DESCRIPTION:Date: Monday\, March 17\, 2025 / 4:00 pm – 5:00 pm EST \nTitle: Navigating the world of ever-changing treatments for youth-onset type 2 diabetes \nDescription: Presentation of different treatment options for youth with Type 2 diabetes \nLearning objectives: \n\nDescribe unique aspects of the pathophysiology of type 2 diabetes and how they affect treatment.\nUnderstand the mechanism for the commonly used medications for treatment of type 2 diabetes.\nApply knowledge of newer treatments to individualize treatment plans for patients with type 2 diabetes.\n\nSpeaker: \nMegan Moriarty Kelsey\, MD\, MS \nAssociate Professor\, Pediatric Endocrinology \nChildren’s Hospital Colorado \nRegister Here
URL:https://pedsendo.org/event/quarterly-education-committee-webinar-navigating-the-world-of-ever-changing-treatments-for-youth-onset-type-2-diabetes/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250328T150000
DTEND;TZID=America/New_York:20250328T160000
DTSTAMP:20241112T234538Z
CREATED:20241112T234538Z
LAST-MODIFIED:20241112T234538Z
UID:24653-1743174000-1743177600@pedsendo.org
SUMMARY:PES SEED Webinar: Approach to Diagnosis and Treatment of Youth Onset Diabetes
DESCRIPTION:Friday\, March 28\, 2025 \n3:00 pm – 4:00 pm EST \nSession Type: SEED \nSession Title: Approach to Diagnosis and Treatment of Youth Onset Diabetes \nBrief Description: This lecture will review the various types of diabetes in youth. The pathophysiology\, diagnostic criteria and treatment of for T1D and T2D will be reviewed in detail. Complications rates will be reviewed in T1D and T2D. There will also be case presentations to review presentation\, work-up\, and management of new onset diabetes in youth. \nLearning objectives: \n\nTo examine the trends in youth onset diabetes prevalence over the past 20 years.\nTo describe the progression and recognize complications of youth onset diabetes.\nTo identify the available treatment modalities available for youth onset diabetes\n\nSpeaker: \nJeanie B. Tryggestad\, MD\, Associate Professor of Pediatrics\, Section Diabetes/Endocrinology\, \nCHF Paul and Ruth Jonas Chair in Pediatric Diabetes/Endocrinology University of Oklahoma Health Sciences \nRegister Here
URL:https://pedsendo.org/event/pes-seed-webinar-approach-to-diagnosis-and-treatment-of-youth-onset-diabetes/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250403T190000
DTEND;TZID=America/New_York:20250403T200000
DTSTAMP:20250325T131155Z
CREATED:20241002T183650Z
LAST-MODIFIED:20250325T131155Z
UID:24469-1743706800-1743710400@pedsendo.org
SUMMARY:State of the Art: Lipid SIG - Sitosterolemia
DESCRIPTION:Thursday\, April 3\, 2025 – State of the Art: Lipid SIG \nSession Title: Sitosterolemia \nBrief Description: \nThe SIG will identify a speaker with special expertise in pediatric lipid disorder. The speaker will discuss rare cholesterol disorders seen in pediatric patients and share diagnostic as well as management challenges associated with such disorders. \nLearning Objectives: \n1. To identify the clinical challenges in diagnosis of rare lipid disorders\n2. To discuss practical approach in management of rare lipid disorders\n3. To discuss challenges in management of rare lipid disorders \nSpeaker: \nAmy Peterson\, MD\, MS\nDivision of Cardiology\, Department of Pediatrics\, University of Wisconsin School of Medicine and Public Health \nRegister Here
URL:https://pedsendo.org/event/state-of-the-art-lipid-sig-rare-cholesterol-disorders/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250429T120000
DTEND;TZID=America/New_York:20250429T130000
DTSTAMP:20241121T191319Z
CREATED:20241112T235909Z
LAST-MODIFIED:20241121T191319Z
UID:24655-1745928000-1745931600@pedsendo.org
SUMMARY:PES Obesity SIG Webinar: Body composition and energy expenditure changes with newer anti-obesity therapies
DESCRIPTION:Tuesday\, April 29\, 2025 \nSession Type SIG: State of the Art: Obesity SIG \nSession Title Body composition and energy expenditure changes with newer anti-obesity therapies \nBrief Description \nTo review the pathophysiology of obesity including body composition\, energy expenditure\, and discuss the newer anti-obesity therapies. \n Learning Objectives  \n\nUnderstand obesity and obesity phenotypes\nDiscuss current data on body composition and energy expenditure with use of newer anti-obesity therapies\nHighlight research gaps and future directions\n\nSpeaker Name \nAndrea Haqq\, MD\nUniversity of Alberta \nRegister Here
URL:https://pedsendo.org/event/pes-obesity-sig-webinar-body-composition-and-energy-expenditure-changes-with-newer-anti-obesity-therapies/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250624T150000
DTEND;TZID=America/New_York:20250624T160000
DTSTAMP:20260615T183719Z
CREATED:20240916T145518Z
LAST-MODIFIED:20260615T183719Z
UID:24402-1750777200-1750780800@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-06-24/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250717T130000
DTEND;TZID=America/New_York:20250717T140000
DTSTAMP:20250710T140720Z
CREATED:20241112T233759Z
LAST-MODIFIED:20250710T140720Z
UID:24649-1752757200-1752760800@pedsendo.org
SUMMARY:PES Bone & Mineral SIG: Current and emerging treatments for hypoparathyroidism
DESCRIPTION:Thursday\, July 17\, 2025 \nSession Type SIG: State of the Art: Bone & Mineral SIG \nSession Title Current and emerging treatments for hypoparathyroidism \nBrief Description \nHypoparathyroidism remains a challenging condition to manage in children. Unlike many endocrine hormone deficiencies\, hormone replacement has never been approved for use in children with parathyroid hormone deficiency. The current standard of care of multiple daily doses of calcium and calcitriol is burdensome\, provides inadequate control of hypocalcemic symptoms\, and is associated with high risk of side effects including nephrocalcinosis. Recent years have seen exciting advancements with a number of new PTH replacement and PTH receptor analog therapies gaining approval in adults and entering into clinical trials for children. This state of the art session will be delivered by Dr Peter Tebben\, a combined pediatric and adult endocrinologist with specific expertise in the management of hypoparathyroidism across the lifespan. Because hypoparathyroidism is widely managed by both general endocrinologists and bone health sub-specialists\, we expect this lecture will be of broad interest to PES members \n  \nLearning Objectives  \n\nRecognize the typical clinical presentation of hypoparathyroidism\nLearn the pathophysiology underlying genetic and acquired forms of hypoparathyroidism\nBecome familiar with current and emerging therapies for the treatment of hypoparathyroidism\n\nSpeaker Name \nPeter Tebben\, MD\nDirector\, Yale Bone Center\nSection of Endocrinology\nYale New Haven Hospital and Yale School of Medicine \nRegister Here
URL:https://pedsendo.org/event/pes-bone-mineral-sig-current-and-emerging-treatments-for-hypoparathyroidism/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250721T160000
DTEND;TZID=America/New_York:20250721T170000
DTSTAMP:20241121T191200Z
CREATED:20241002T184132Z
LAST-MODIFIED:20241121T191200Z
UID:24473-1753113600-1753117200@pedsendo.org
SUMMARY:Quarterly Education Committee Webinar: Updated Clinical Practice Guidelines for Turner Syndrome
DESCRIPTION:Date: Monday\, July 21\, 2025 / 4:00 pm – 5:00 pm EST \nTitle: Updated Clinical Practice Guidelines for Turner Syndrome \nDescription: A presentation on the new guidelines presented for Turner syndrome \nLearning objectives: \n\n Review the advances in the diagnostics and genetics of Turner syndrome\nHormone replacement therapy in Turner syndrome: what is new?\nRole of the pediatric endocrine provider in comprehensive healthcare delivery for Turner syndrome\n\nSpeaker: \nRoopa Kanakatti Shankar\, MD\, MS \nAssociate Professor of Pediatrics \nGeorge Washington University School of Medicine and Health Sciences \nDirector\, Turner Syndrome Program \nDivision of Endocrinology \nChildren’s National Hospital \n\n\n\n\n\nRegister Here
URL:https://pedsendo.org/event/quarterly-education-committee-webinar-updated-clinical-practice-guidelines-for-turner-syndrome/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250722T150000
DTEND;TZID=America/New_York:20250722T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27773-1753196400-1753200000@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-07-22/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250804T110000
DTEND;TZID=America/New_York:20250804T120000
DTSTAMP:20241121T191145Z
CREATED:20240724T124958Z
LAST-MODIFIED:20241121T191145Z
UID:24280-1754305200-1754308800@pedsendo.org
SUMMARY:PES APP SIG meeting
DESCRIPTION:The PES APP SIG is focused on the unique education and practice needs of pediatric endocrine APPs\, thereby aligning with the PES strategic plan goals of supporting the pediatric endocrine workforce\, increasing interprofessional membership and involvement\, providing high-quality clinical education\, and advocating for the needs of patients\, their families and our members. \n  \nIf you’re interested in joining the APP SIG\, click here.
URL:https://pedsendo.org/event/pes-app-sig-meeting/2025-08-04/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250826T150000
DTEND;TZID=America/New_York:20250826T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27774-1756220400-1756224000@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-08-26/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250827T160000
DTEND;TZID=America/New_York:20250827T170000
DTSTAMP:20250827T193612Z
CREATED:20250827T193612Z
LAST-MODIFIED:20250827T193612Z
UID:26129-1756310400-1756314000@pedsendo.org
SUMMARY:PES Leader Orientation
DESCRIPTION:For New and Returning SIG and Committee Leaders! Reach out to info@pedsendo.org for more information or the zoom link. \n  \nThe session will be recorded and made available to leaders following.
URL:https://pedsendo.org/event/pes-leader-orientation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250903T180000
DTEND;TZID=America/New_York:20250903T190000
DTSTAMP:20250813T130902Z
CREATED:20250813T130902Z
LAST-MODIFIED:20250813T130902Z
UID:26027-1756922400-1756926000@pedsendo.org
SUMMARY:PES Turner Syndrome SIG
DESCRIPTION:For more information on the TS SIG\, click here. \nTo join a SIG\, click here. \n 
URL:https://pedsendo.org/event/pes-turner-syndrome-sig/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250905T160000
DTEND;TZID=America/New_York:20250905T170000
DTSTAMP:20250818T151824Z
CREATED:20250818T151824Z
LAST-MODIFIED:20250818T151824Z
UID:26038-1757088000-1757091600@pedsendo.org
SUMMARY:PES Public Policy Committee Meeting
DESCRIPTION:For more information on the Public Policy Committee\, click here. \nTo join a committee\, click here.
URL:https://pedsendo.org/event/pes-public-policy-committee-meeting/2025-09-05/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250910T120000
DTEND;TZID=America/New_York:20250910T130000
DTSTAMP:20251017T165038Z
CREATED:20250811T141732Z
LAST-MODIFIED:20251017T165038Z
UID:26020-1757505600-1757509200@pedsendo.org
SUMMARY:Industry Sponsored Symposium: Navigating CAH: An Interactive Case Study Approach for Pediatric Specialists
DESCRIPTION:September 10\, 2025 | 12:00 – 1:00 PM ET \nSponsored by: Medscape Education. Supported by an independent educational grant from Neurocrine Biosciences\, Inc. \nPROGRAM DESCRIPTION \nCongenital adrenal hyperplasia (CAH) presents complex\, lifelong challenges that impact patients’ quality of life—from growth suppression in children to long-term metabolic and psychological effects. This symposium offers clinicians a unique opportunity to build confidence in managing CAH\, especially amid the emergence of innovative therapies that may reduce reliance on glucocorticoids. Gain insights into timely diagnosis\, individualized treatment strategies\, and optimizing care during critical transitions such as puberty and adulthood. \nJoin us to explore cutting-edge advances and improve outcomes for pediatric and adolescent patients living with this rare\, often misunderstood condition. Empower your practice with the latest in CAH management. \nLearning objectives: \nUpon completion of this activity\, participants will have greater competence related to: \n\nUse of new therapeutic approaches for managing pediatric/adolescent patients with CAH\nComprehensive care in pediatric/adolescent patients with CAH\nTimely diagnosis and management (including intensification or adjustment to pharmacologic management) in pediatric/adolescent patients with CAH\n\nDemonstrate greater confidence in their ability to: \n\nComprehensively manage CAH in the pediatric population\n\nCMEs will be offered. \nSPEAKERS: \n\nRichard J. Auchus\, MD\, PhD\, FACE\n​The James A. Shayman and Andrea\nS. Kevrick Professor of Translational Medicine\, Division of Metabolism\, Endocrinology and Diabetes\n​Departments of Internal Medicine and Pharmacology\, ​University of Michigan Medical School\, ​Ann Arbor\, Michigan​\n​​Patricia Y. Fechner\, MD\n​Professor of Pediatrics\n​University of Washington School of Medicine\, ​Medical Director\n​Seattle Children’s CAH Center of Excellence\, ​Seattle\, Washington\nPhyllis W. Speiser\, MD\n​Emeritus Professor of Pediatrics\n​Zucker School of Medicine at Hofstra/Northwell\n​Hempstead\, New York​\n\nView the recording here \nSponsored by Medscape Education. Supported by an independent educational grant from Neurocrine Biosciences\, Inc.  
URL:https://pedsendo.org/event/industry-sponsored-symposium-navigating-cah-an-interactive-case-study-approach-for-pediatric-specialists/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250910T180000
DTEND;TZID=America/New_York:20250910T190000
DTSTAMP:20250821T144300Z
CREATED:20250818T171644Z
LAST-MODIFIED:20250821T144300Z
UID:26041-1757527200-1757530800@pedsendo.org
SUMMARY:Ethics and DSD Journal Club: What's in a name?
DESCRIPTION:Brief Description  \nYou are invited to join an interactive discussion of a recent commentary published in Nature Reviews Urology titled “Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD” (https://doi.org/10.1038/s41585-025-01035-5). Part of the discussion will include an opportunity to hear from and dialogue with some of the authors.  \n Learning Objectives   \n\n Understand the history behind terminology related to differences or variations in sex characteristics\n Appreciate different perspectives on preferred terminology\n Reflect on the ethical implications of careful attention to language\n\n Speaker Name(s)  \nJ Whitehead\, Lurie Children’s Hospital \nAdam Davies\, Northwestern School of Medicine \n Marissa Adams\, Independent Researcher
URL:https://pedsendo.org/event/ethics-and-dsd-journal-club-whats-in-a-name/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250923T150000
DTEND;TZID=America/New_York:20250923T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27775-1758639600-1758643200@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-09-23/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251001T140000
DTEND;TZID=America/New_York:20251001T150000
DTSTAMP:20250908T143429Z
CREATED:20250908T143429Z
LAST-MODIFIED:20250908T143429Z
UID:26147-1759327200-1759330800@pedsendo.org
SUMMARY:Industry Sponsored Symposium: A New Treatment Era for Congenital Adrenal Hyperplasia: Androgen Management and Glucocorticoid Dose Reduction in Clinical Practice
DESCRIPTION:Industry Sponsored Symposium: A New Treatment Era for Congenital Adrenal Hyperplasia: Androgen Management and Glucocorticoid Dose Reduction in Clinical Practice\n \nOctober 1\, 2025 I 12:00 – 1:00 PM MT (2pET)\nSponsored by: Neurocrine Biosciences \nPROGRAM DESCRIPTION \nThis interactive\, case-based presentation will provide an in-depth look at clinical data for a newly approved\, non-glucocorticoid treatment for classic congenital adrenal hyperplasia (CAH) and will feature a clinical conversation about how to reduce glucocorticoids and manage androgens in real-world clinical practice. It will also provide a refresher on CAH pathophysiology and the impact of high androgens and chronic high dose glucocorticoid treatment in pediatric patients with CAH. \nLearning objectives: \nThis interactive\, case-based presentation will provide an in-depth look at clinical data for a newly approved\, non-glucocorticoid treatment for classic congenital adrenal hyperplasia (CAH) and will feature a clinical conversation about how to reduce glucocorticoids and manage androgens in real-world clinical practice. It will also provide a refresher on CAH pathophysiology and the impact of high androgens and chronic high dose glucocorticoid treatment in pediatric patients with CAH. \nCME credit will not be offered for this activity. \nSPEAKERS: \n\nNatalie Nokoff\, MD\, PhD​\nAssociate Professor​\, Department of Pediatric Endocrinology​\nAnschutz Medical Campus​\, Aurora\, CO\n\nRegister here \nNeurocrine Biosciences\, Inc.  
URL:https://pedsendo.org/event/industry-sponsored-symposium-a-new-treatment-era-for-congenital-adrenal-hyperplasia-androgen-management-and-glucocorticoid-dose-reduction-in-clinical-practice/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251007T190000
DTEND;TZID=America/New_York:20251007T200000
DTSTAMP:20250916T182052Z
CREATED:20250916T182027Z
LAST-MODIFIED:20250916T182052Z
UID:26163-1759863600-1759867200@pedsendo.org
SUMMARY:Industry Sponsored Symposium: Managing Achondroplasia Together: Physician and Caregiver Perspectives
DESCRIPTION:Industry Sponsored Symposium: Managing Achondroplasia Together: Physician and Caregiver Perspectives \nSponsored by BioMarin Pharmaceutical Inc. \nOctober 7th 7:00-8:00 pm ET \n  \nLearn about the underlying cause of inhibited bone growth in achondroplasia and explore management options with a clinical expert.   Hear from a caregiver as they share their experiences and perspectives navigating achondroplasia. \n  \nSpeaker  \nPedro A. Sanchez\, MD\, FAAP\, FACMG \nDirector of Pediatric Medical Genetics \nCedars-Sinai Medical Center \n  \nRegister here: Managing Achondroplasia Together: Physician and Caregiver Perspectives \n  \nSponsored by BioMarin Pharmaceutical Inc.
URL:https://pedsendo.org/event/industry-sponsored-symposium-managing-achondroplasia-together-physician-and-caregiver-perspectives/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251009T170000
DTEND;TZID=America/New_York:20251009T180000
DTSTAMP:20250916T181752Z
CREATED:20250916T181752Z
LAST-MODIFIED:20250916T181752Z
UID:26161-1760029200-1760032800@pedsendo.org
SUMMARY:PES Obesity SIG Meeting
DESCRIPTION:For more information on the Obesity SIG\, click here. \nTo join a SIG\, click here.
URL:https://pedsendo.org/event/pes-obesity-sig-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251014T200000
DTEND;TZID=America/New_York:20251014T210000
DTSTAMP:20250812T201054Z
CREATED:20250721T131957Z
LAST-MODIFIED:20250812T201054Z
UID:25902-1760472000-1760475600@pedsendo.org
SUMMARY:PES Podcast Club: The Immortal Life of Henrietta Lacks
DESCRIPTION:Podcast Club: The Immortal Life of Henrietta Lacks \nTuesday\, October 14\, 2025\, 8:00pm Eastern time \nWe’re excited to announce that we will be discussing The Immortal Life of Henrietta Lacks and its related podcast. \nThe Immortal Life of Henrietta Lacks \nJoin us for robust discussion: https://zoom.us/meeting/register/fyPzlN_JSh-h1ydgUzTuaw \nThe Immortal Life of Henrietta Lacks \nHow one woman\, without her knowing\, may have saved us all.
URL:https://pedsendo.org/event/pes-podcast-club/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251020T160000
DTEND;TZID=America/New_York:20251020T170000
DTSTAMP:20250904T133552Z
CREATED:20241002T184524Z
LAST-MODIFIED:20250904T133552Z
UID:24475-1760976000-1760979600@pedsendo.org
SUMMARY:Quarterly Education Committee Webinar: Dyslipidemia in Diabetes and Beyond
DESCRIPTION:Date: Monday\, October 20\, 2025 / 4:00 pm – 5:00 pm EST \nTitle: Dyslipidemia in Diabetes and Beyond \nLearning objectives: \n\n\nAnalyze the pathophysiology between dyslipidemia and diabetes\n\n\nAssess current evidence-based guidelines and management strategies for managing dyslipidemia in pediatric diabetes and other high risk pediatric populations\n\n\nDevelop tailored interventions for those who do not respond to standard dyslipidemia treatment\n\n\nSpeaker: \nGrace Kim\, MD \nRegister Here
URL:https://pedsendo.org/event/quarterly-education-committee-webinar-update-on-use-of-technology-for-management-of-diabetes/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251028T150000
DTEND;TZID=America/New_York:20251028T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27776-1761663600-1761667200@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-10-28/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251029T170000
DTEND;TZID=America/New_York:20251029T180000
DTSTAMP:20251014T200249Z
CREATED:20250818T194305Z
LAST-MODIFIED:20251014T200249Z
UID:26048-1761757200-1761760800@pedsendo.org
SUMMARY:Primary Ovarian Insufficiency in Pediatric Cancer Survivors 
DESCRIPTION:Wednesday\, October 29\, 2025  \n5:00 PM EST  \nSession Type SIG: State of the Art: TREND SIG  \nSession Title Primary Ovarian Insufficiency in Pediatric Cancer Survivors  \nBrief Description  \nOvarian dysfunction is a frequent late – effect in pediatric cancer survivors- however it is important to understand how ovarian secretory function and reproductive function are affected differetnly. We will discuss utility of markers for fertility prognostication\, when to refer to repro-endo\, and recommendations for counseling patients. Cases will be presented and an expert panel will help facilitate discussion.  \nLearning Objectives   \n\n To describe the impact of cancer and its treatments on female fertility; \n To outline the various fertility preservation options available \n To identify resources and strategies for supporting patients in making informed decisions about fertility preservation\n\n Speaker Name(s)  \nDr. Jennifer Levine  \nDr. Levine is the Medical Director for Survivorship and Supportive Care at Children’s National Hospital in Washington DC. Her clinical areas of expertise are in leukemia\, lymphoma\, and the late effects of cancer treatment. Her research interests have primarily been in the field of oncofertility. 
URL:https://pedsendo.org/event/primary-ovarian-insufficiency-in-pediatric-cancer-survivors/
END:VEVENT
END:VCALENDAR